Showing results (341-350 of 360) with videos related to
Sort By:
Pageof 36
Journal of Immigrant and Minority Health|October 9, 2020
Effective Recruitment Strategies for a Sickle Cell Patient Registry Across Sites from the Sickle Cell Disease Implementation Consortium (SCDIC)Rita V Masese, Terri DeMartino, Emily Bonnabeau, et al.International Journal for Equity in Health|February 23, 2017
Implementing guidelines and training initiatives to improve cross-cultural communication in primary care consultations: a qualitative participatory European studyE Teunissen, K Gravenhorst, C Dowrick, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 8, 2015
Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058David S Metzger, Deborah Donnell, David D Celentano, et al.The Lancet. Infectious Diseases|July 29, 2014
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort studyRobert M Grant, Peter L Anderson, Vanessa McMahan, et al.The Lancet. Microbe|December 11, 2023
Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART studyMatthew Hall, Tanya Golubchik, David Bonsall, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 19, 2021
Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized TrialsSimbarashe Takuva, Shelly T Karuna, Michal Juraska, et al.Animal Genetics|October 13, 2018
Generation of an equine biobank to be used for Functional Annotation of Animal Genomes projectE N Burns, M H Bordbari, M J Mienaltowski, et al.Nature Microbiology|October 8, 2024
Cryptosporidium PI(4)K inhibitor EDI048 is a gut-restricted parasiticidal agent to treat paediatric enteric cryptosporidiosisUjjini H Manjunatha, Suresh B Lakshminarayana, Rajiv S Jumani, et al.Open Forum Infectious Diseases|August 30, 2021
Engaging People Who Inject Drugs Living With HIV in Antiretroviral Treatment and Medication for Opioid Use Disorder: Extended Follow-up of HIV Prevention Trials Network (HPTN) 074Kathryn E Lancaster, Katie R Mollan, Brett S Hanscom, et al.Lancet (London, England)|September 8, 2018
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy studyWilliam C Miller, Irving F Hoffman, Brett S Hanscom, et al.Pageof 36